WALSH MATTHEW M 4
4 · Organon & Co. · Filed Mar 3, 2026
Insider Transaction Report
Form 4
WALSH MATTHEW M
Chief Financial Officer
Transactions
- Award
Common Stock
[F1]2026-02-27+42,599→ 187,083 total - Tax Payment
Common Stock
2026-02-27$7.17/sh−14,887$106,740→ 172,196 total - Award
Common Stock
[F2]2026-02-27+12,020→ 184,216 total - Tax Payment
Common Stock
[F3]2026-02-27$7.23/sh−4,117$29,766→ 180,751 total
Footnotes (3)
- [F1]Represents shares of Organon & Co. common stock ("Common Stock") for performance share units ("PSUs") granted to the reporting person on August 11, 2023 under the Organon & Co. 2021 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors.
- [F2]Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above.
- [F3]Includes the addition of 652 shares of Common Stock acquired from dividend equivalents net of withholding tax not previously required to be reported.
Signature
/s/ Faye C. Brown, as Attorney-in-Fact for Matthew M. Walsh|2026-03-03